Aurora Announces Results of 2020 Annual General and Special Meeting

Rhea-AI Summary

Aurora Cannabis Inc. (ACB) announced results from its Annual General and Special Meeting held on November 12, 2020. A total of 48,828,603 shares, representing 40.34% of the issued shares, were represented at the meeting. Key approvals included the election of directors, the appointment of KPMG LLP as auditors, and the renewal of a 10% rolling stock option plan. Notably, Miguel Martin secured 90.05% of votes in favor of his position. The company remains a global cannabis leader, dedicated to serving both medical and consumer markets.

Positive

• Approval of all matters presented to shareholders.
• Strong support for director Miguel Martin with 90.05% of votes.
• Appointment of KPMG LLP as auditors, ensuring financial oversight.
• Approval of stock option plan renewal, supporting employee retention.

Negative

• None.

NYSE | TSX: ACB

EDMONTON, AB, Nov. 16, 2020 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) ( TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders (the "Meeting") held on Thursday, November 12, 2020 by virtual webcast. The total number of shares represented by shareholders present in person and by proxy at the Meeting was 48,828,603, representing 40.34% of Aurora's issued and outstanding common shares.

All of the matters put forward before shareholders for consideration and approval, as set out in the Company's Management Information Circular dated September 28, 2020, were approved by the requisite majority of votes cast at the Meeting. The details of the voting results for the election of directors are set out below:

Nominee	Votes For	Votes Withheld
Miguel Martin	9,114,731 (90.05%)	1,007,078 (9.95%)
Michael Singer	8,327,088 (82.27%)	1,794,722 (17.73%)
Ron Funk	8,920,391 (88.13%)	1,201,419 (11.87%)
Norma Beauchamp	8,901,696 (87.95%)	1,220,113 (12.05%)
Margaret Shan Atkins	8,965,142 (88.57%)	1,156,667 (11.43%)
Adam Szweras	8,642,769 (85.39%)	1,479,040 (14.61%)
Michael Detlefsen	9,009,767 (89.01%)	1,112,043 (10.99%)
Lance Friedmann	8,894,788 (87.88%)	1,227,022 (12.12%)

Shareholders also approved the following matters:

• appointment of KPMG LLP as auditors of the Company for the ensuing year;
• renewal of the Company's 10% "rolling" stock option plan;
• adoption of the Company's fixed performance share unit plan;
• an amendment to each of the Company's fixed restricted share unit plan and fixed deferred share unit plan to increase the number of common shares issuable under each plan; and
• a non-binding advisory resolution on the Company's approach to executive compensation

The Company has filed a report of voting results on all resolutions voted on at the Meeting on www.sedar.com

About Aurora 

Aurora is a global leader in the cannabis industry serving both the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. The Company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and Reliva CBD. Providing customers with innovative, high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, performance, wellness and recreational markets wherever they are launched. For more information, please visit our website at www.auroramj.com.

Aurora's Common Shares trade on the TSX and NYSE under the symbol "ACB", and is a constituent of the S&P/TSX Composite Index.

Forward Looking Statements

This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

View original content to download multimedia:http://www.prnewswire.com/news-releases/aurora-announces-results-of-2020-annual-general-and-special-meeting-301173281.html

SOURCE Aurora Cannabis Inc.

FAQ

What were the results of Aurora Cannabis' 2020 Annual General Meeting?

Aurora Cannabis' 2020 Annual General Meeting resulted in the approval of all presented matters, including director elections and financial decisions.

Who received the most votes at the ACB shareholder meeting?

Miguel Martin received the most votes at 90.05% in favor of his director position at the ACB shareholder meeting.

What percentage of shares were represented at Aurora's Annual General Meeting?

At Aurora's Annual General Meeting, 40.34% of the company's issued and outstanding common shares were represented.

What new plans were approved for Aurora Cannabis at the meeting?

The meeting approved the renewal of Aurora's 10% rolling stock option plan and a fixed performance share unit plan.

Which auditors were appointed during the Aurora Cannabis shareholder meeting?

KPMG LLP was appointed as the auditors for Aurora Cannabis during the shareholder meeting.